Tong Xinchun S, Wang Junying, Zheng Song, Pivnichny James V
Basic Chemistry, Merck Research Laboratory, Merck & Co. Inc., P.O. Box 2000, RY800-B205, Rahway, NJ 07065, USA.
J Pharm Biomed Anal. 2004 Jun 29;35(4):867-77. doi: 10.1016/j.jpba.2004.02.017.
Automation of plasma sample preparation for pharmacokinetic studies on VLA-4 antagonists has been achieved by using 96-well format solid-phase extraction operated by Beckman Coulter Biomek 2000 liquid handling system. A Biomek 2000 robot is used to perform fully automated plasma sample preparation tasks that include serial dilution of standard solutions, pipetting plasma samples, addition of standard and internal standard solutions, performing solid-phase extraction (SPE) on Waters OASIS 96-well plates. This automated sample preparation process takes less than 2 h for a typical pharmacokinetic study, including 51 samples, 24 standards, 9 quality controls, and 3-6 dose checks with minimal manual intervention. Extensive validation has been made to ensure the accuracy and reliability of this method. A two-stage vacuum pressure controller has been incorporated in the program to improve SPE efficiency. This automated SPE sample preparation approach combined with liquid chromatography coupled with the high sensitivity and selectivity of tandem mass spectrometry (LC/MS)/MS has been successfully applied on both individual and cassette dosing for pharmacokinetic screening of a large number of VLA-4 antagonists with a limit of quantitation in the range of 1-5 ng/ml. Consequently, a significant throughput increase has been achieved along with an elimination of tedious labor and its consequential tendency to produce errors.
通过使用贝克曼库尔特Biomek 2000液体处理系统操作的96孔板固相萃取,实现了VLA - 4拮抗剂药代动力学研究中血浆样品制备的自动化。Biomek 2000机器人用于执行完全自动化的血浆样品制备任务,包括标准溶液的系列稀释、吸取血浆样品、添加标准溶液和内标溶液、在Waters OASIS 96孔板上进行固相萃取(SPE)。对于典型的药代动力学研究,包括51个样品、24个标准品、9个质量控制品以及3 - 6次剂量检查,这种自动化样品制备过程在最少人工干预的情况下耗时不到2小时。已经进行了广泛的验证以确保该方法的准确性和可靠性。程序中加入了两级真空压力控制器以提高SPE效率。这种自动化的SPE样品制备方法与液相色谱相结合,并结合串联质谱(LC/MS)/MS的高灵敏度和选择性,已成功应用于单个给药和组合给药,用于大量VLA - 4拮抗剂的药代动力学筛选,定量限在1 - 5 ng/ml范围内。因此,实现了显著的通量增加,同时消除了繁琐的劳动及其产生误差的相应倾向。